Ezra M. Friedberg is Director at Pelthos Therapeutics Inc. (PTHS). They have made 2 open-market trades across 2 companies since 2024, most recently 2026-07-02.
CIK 0001679440
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2024, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTHS | 81,042 | $1.6M |
| CHRO | 545,721 | $737K |
| Total | $2.4M |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTHS | SELL · 10b5-1 | 2026-07-02 | 2026-07-07 | $26.09 | $15K | +14.2% | +19.5% | -15.0% |
| PTHS | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $27.29 | $8K | +3.8% | +3.4% | -20.9% |
| PTHS | SELL · 10b5-1 | 2026-04-02 | 2026-04-06 | $20.92 | $12K | -8.0% | +0.0% | -2.0% |
| PTHS | SELL | 2025-11-25 | 2025-11-26 | $28.03 | $280K | -11.1% | -9.7% | -18.4% |
| CHRO | BUY | 2024-02-21 | 2024-03-12 | $6.00 | $100K | -33.2% | -50.3% | -64.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.